Cargando…
Overexpression of Annexin A1 Suppresses Pro-Inflammatory Factors in PC12 Cells Induced by 1-Methyl-4-Phenylpyridinium
OBJECTIVE: Annexin A1 (ANXA1) is suggested to have anti-inflammatory function. However, the precise function of ANXA1 has remained unclear. In this study, we therefore examined the potency of ANXA1 in regulating reactive oxygen species (ROS) production and suppressing pro-inflammatory responses in P...
Autores principales: | Kiani-Esfahani, Abbas, Kazemi Sheykhshabani, Sedigheh, Peymani, Maryam, Hashemi, Motahare-Sadat, Ghaedi, Kamran, Nasr-Esfahani, Mohammad Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988418/ https://www.ncbi.nlm.nih.gov/pubmed/27540524 |
Ejemplares similares
-
Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson’s disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms
por: Behbahanipour, Molood, et al.
Publicado: (2019) -
Downregulation of miR-130a, antagonized doxorubicin-induced cardiotoxicity via increasing the PPARγ expression in mESCs-derived cardiac cells
por: Pakravan, Golnaz, et al.
Publicado: (2018) -
Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease
por: Fazeli, Soudabeh, et al.
Publicado: (2020) -
A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease
por: Fazeli, Soudabeh, et al.
Publicado: (2020) -
Upregulation of miR‐200a and miR‐204 in MPP(+)‐treated differentiated PC12 cells as a model of Parkinson’s disease
por: Talepoor Ardakani, Maryam, et al.
Publicado: (2019)